'Significant milestone' as STARLIMS acquires Labstep to unlock lab data's full potential

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags Lab research R&D electronic lab notebook

STARLIMS, a company that provides enterprise informatics solutions has acquired Labstep, a research and development (R&D) electronic laboratory notebook (ELN).

The companies believe the acquisition will address critical challenges customers face in finding an advanced platform to support to support them from R&D through to market surveillance.

They said combining STARLIMS’ laboratory information management system (LIMS) technology with Labstep’s SaaS ELN platform users can remove the difficulty from the lab and unlock their data’s full potential in a progressive, connected system.

The acquisition of Labstep represents a significant milestone STARLIMS says, as it introduces a ‘modern and user-friendly ELN to its existing platform’.

Benefits of the integration include accelerating ideation and planning through easy-to-use documentation functionality, automation capabilities, and seamless connectivity to instruments and systems, moving users away from cumbersome paper-based record keeping.

STARLIMS said the unified solution will liberate scientists from manual documentation, leaving them with more time to conduct research.

“We are thrilled to bring Labstep into our portfolio. Labstep's high-caliber team, coupled with its forward-thinking approach to addressing industry challenges, makes it an excellent addition to STARLIMS," said Trey Cook, CEO at STARLIMS.

"Their user-centric approach has resulted in an intuitive ELN for science that allows research and development teams to increase the speed of ideation and new product introduction, while giving them a modern, simplified experience.”

Labstep states its ELN uses interactive, step-by-step protocols as templates for data collection to ensure continuous data capture for researchers. The solution was created by a team of scientists, for scientists, with the goal of building a progressive operating system that reflects the needs of the modern R&D lab.

Jake Schofield, CEO & founder at Labstep, said: “We’re excited to be joining the STARLIMS’ team and its robust set of solutions. As a recognized leader in LIMS technology, it was a natural next step for us to take Labstep to the next level.

“Together, our solutions create a connected platform that not only accelerates R&D, but also supports the product throughout its entire lifecycle. The mission to simplify workflows and enhance productivity will ultimately advance scientific discovery, and help companies bring innovative, quality products to market faster.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more